Bal Pharma surges despite reporting 53.56% fall in Q4 net profit

11 May 2012 Evaluate

Bal Pharma is currently trading at Rs. 20.00, up by 0.75 points or 3.90% from its previous closing of Rs. 19.25 on the BSE.

The scrip opened at Rs. 22.00 and has touched a high and low of Rs. 22.00 and Rs. 20.00 respectively. So far 1004 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 33.70 on 19-May-2011 and a 52 week low of Rs. 15.50 on 23-Dec-2011.

Last one week high and low of the scrip stood at Rs. 22.00 and Rs. 19.05 respectively. The current market cap of the company is Rs. 21.15 crore.

The promoters holding in the company stood at 51.46% while Institutions and Non-Institutions held 0.02% and 48.52% respectively. 

Bal Pharma has reported results for fourth quarter ended March 31, 2012.

The company has posted a fall of 53.56% in its net profit at Rs 1.63 crore for the quarter ended March 31, 2012 as compared to Rs 3.51 crore for the same quarter in the previous year.  However, total income has increased by 4.54% at Rs 39.67crore for quarter under review as compared Rs 37.95 crore for the quarter ended March 31, 2011.

Bal Pharma Share Price

71.75 -2.82 (-3.78%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×